Interferon
COVID-19: Autoantibodies can cause severe disease and deaths
Various studies have revealed that autoantibodies have been a key driver of severe illness and deaths amongst people critically infected with COVID-19. Findings also show that autoantibodies’ concentration in human bodies increases with age
WHO mega trial results out: Remdesivir, Interferon fail to prove effective
None of the four drug/drug combinations that were deployed in the WHO’s SOLIDARITY trial were found to be effective in reducing mortality, not even the much-hyped anti-viral drug Remdesivir
- Uruguay’s Broad Front government renews search for those disappeared by military dictatorship
- Jordan bans Muslim Brotherhood, confiscates its assets after alleged security plot
- Medics on hunger strike against Gaza genocide reach European Parliament
- Samidoun Europe coordinator targeted again by Belgian police
- Syria’s interim government arrests senior Palestinian resistance leaders
